$2.72T
Total marketcap
$94.38B
Total volume
BTC 49.78%     ETH 17.01%
Dominance

Amgen AMGN Stock

300.19 USD {{ price }} -1.847369% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
161.03B USD
LOW - HIGH [24H]
298.31 - 303.51 USD
VOLUME [24H]
2.28M USD
{{ volume }}
P/E Ratio
42.88
Earnings per share
7 USD

Amgen Price Chart

Amgen AMGN Financial and Trading Overview

Amgen stock price 300.19 USD
Previous Close 222.28 USD
Open 223.01 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 222.97 - 228.85 USD
52 Week Range 211.71 - 296.67 USD
Volume 2.63M USD
Avg. Volume 2.34M USD
Market Cap 122.06B USD
Beta (5Y Monthly) 0.642957
PE Ratio (TTM) 15.529572
EPS (TTM) 7 USD
Forward Dividend & Yield 8.52 (3.83%)
Ex-Dividend Date May 17, 2023
1y Target Est 254.55 USD

AMGN Valuation Measures

Enterprise Value 148.8B USD
Trailing P/E 15.529572
Forward P/E 12.125265
PEG Ratio (5 yr expected) 7.25
Price/Sales (ttm) 4.6606207
Price/Book (mrq) 22.82346
Enterprise Value/Revenue 5.682
Enterprise Value/EBITDA 11.34

Trading Information

Amgen Stock Price History

Beta (5Y Monthly) 0.642957
52-Week Change -2.67%
S&P500 52-Week Change 20.43%
52 Week High 296.67 USD
52 Week Low 211.71 USD
50-Day Moving Average 232.81 USD
200-Day Moving Average 248.07 USD

AMGN Share Statistics

Avg. Volume (3 month) 2.34M USD
Avg. Daily Volume (10-Days) 2.42M USD
Shares Outstanding 534.33M
Float 533.2M
Short Ratio 3.21
% Held by Insiders 0.21%
% Held by Institutions 79.82%
Shares Short 7.41M
Short % of Float 1.38%
Short % of Shares Outstanding 1.38%

Dividends & Splits

Trailing Annual Dividend Rate 7.95
Trailing Annual Dividend Yield 3.57%
5 Year Average Dividend Yield 288.00%
Payout Ratio 0.5404
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 30.22%
Operating Margin (ttm) 36.83%
Gross Margin 74.93%
EBITDA Margin 50.10%

Management Effectiveness

Return on Assets (ttm) 8.15%
Return on Equity (ttm) 252.77%

Income Statement

Revenue (ttm) 26.19B USD
Revenue Per Share (ttm) 49 USD
Quarterly Revenue Growth (yoy) -2.10%
Gross Profit (ttm) 19.92B USD
EBITDA 13.12B USD
Net Income Avi to Common (ttm) 7.92B USD
Diluted EPS (ttm) 14.71
Quarterly Earnings Growth (yoy) 92.50%

Balance Sheet

Total Cash (mrq) 31.56B USD
Total Cash Per Share (mrq) 59.07 USD
Total Debt (mrq) 61.6B USD
Total Debt/Equity (mrq) 1151.74 USD
Current Ratio (mrq) 3.145
Book Value Per Share (mrq) 10.009

Cash Flow Statement

Operating Cash Flow (ttm) 8.62B USD
Levered Free Cash Flow (ttm) 7.95B USD

Profile of Amgen

Country United States
State CA
City Thousand Oaks
Address One Amgen Center Drive
ZIP 91320-1799
Phone 805 447 1000
Website https://www.amgen.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 25200

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Q&A For Amgen Stock

What is a current AMGN stock price?

Amgen AMGN stock price today per share is 300.19 USD.

How to purchase Amgen stock?

You can buy AMGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Amgen?

The stock symbol or ticker of Amgen is AMGN.

Which industry does the Amgen company belong to?

The Amgen industry is Drug Manufacturers-General.

How many shares does Amgen have in circulation?

The max supply of Amgen shares is 536.43M.

What is Amgen Price to Earnings Ratio (PE Ratio)?

Amgen PE Ratio is 42.88428500 now.

What was Amgen earnings per share over the trailing 12 months (TTM)?

Amgen EPS is 7 USD over the trailing 12 months.

Which sector does the Amgen company belong to?

The Amgen sector is Healthcare.

Amgen AMGN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 17019.88 USD
+0.59
5.94B USD 16917.51 USD 17032.66 USD 5.94B USD
S&P 500 INDEX SPX 5306.04 USD
+0.02
2.11B USD 5280.89 USD 5315.91 USD 2.11B USD
S&P 500 (Yahoo.com) GSPC 5306.04 USD
+0.02
2.1B USD 5280.89 USD 5315.91 USD 2.1B USD
S&P 100 SP100 2543.27 USD
+0.4
1B USD 2528.85 USD 2544.01 USD 1B USD
US100 NDX 18869.44 USD
+0.32
790.21M USD 18755.95 USD 18875.2 USD 790.21M USD
Dow Jones Industrial Average DJI 38852.86 USD
-0.55
306.72M USD 38706.14 USD 39028.99 USD 306.72M USD
Dow Jones U.S. Biotechnology In DJUSBT 2788.68 USD
-1.77
75.07M USD 2774.4 USD 2831.07 USD 75.07M USD
NASDAQ 100 Notional Net Total R XNDXNNR 21744.75 USD
+0.32
21613.97 USD 21751.38 USD
Nasdaq CRD Global Sustainabilit NQCRD 1735.62 USD
0
1715.94 USD 1757.95 USD
NASDAQ US Broad Dividend Achiev DAA 3416.04 USD
-0.72
3404.92 USD 3438.66 USD
Nasdaq-100 Micro Index XND 188.69 USD
+0.32
187.56 USD 188.75 USD
The Capital Strength Index seek NQCAPST 3017.17 USD
-1.18
3010.41 USD 3047.23 USD
Nasdaq-100 ESG Net Notional Tot NDXESG24 1550.14 EUR 1694.51 USD
+0.24
1541.34 EUR 1684.89 USD 1552.58 EUR 1697.18 USD
NASDAQ Composite Total Return I XCMP 20705.72 USD
+0.59
20581.18 USD 20721.26 USD
NASDAQ 100 Equal Weighted NDXE 7414.44 USD
-0.73
7383.62 USD 7464.29 USD
NASDAQ 100 After Hours Indicato QIV 18879.58 USD
+0.38
18872.76 USD 18884.8 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ OMX CRD Global Sustainab QCRD 1595.1 USD
0
Nasdaq US Low Volatility Divide LVDA 1171.68 USD
-1.01
1169.52 USD 1181.91 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1390.47 USD
-1.31
1384.85 USD 1407.09 USD